|
業務類別
|
Drug Manufacturers - General |
|
業務概覽
|
A merger between Astra of Sweden and Zeneca of the United Kingdom formed AstraZeneca in 1999. The firm sells branded drugs across a number of major therapeutic areas, including oncology (over 40% of total revenue), cardiovascular, renal, and metabolic (over 20%), rare disease (16%), and respiratory and immunology (15%). The majority of sales comes from international markets, with the United States representing close to one-third of its sales. |
| 公司地址
| 1 Francis Crick Avenue, Cambridge Biomedical Campus, Cambridge, GBR, CB2 0AA |
| 電話號碼
| +44 2037495000 |
| 傳真號碼
| +44 1223352858 |
| 公司網頁
| https://www.astrazeneca.com |
| 員工數量
| 94300 |
| Admiral Matthew Shaun Bowden |
Company Secretary |
-- |
10/03/2026 |
| Mr. Pascal Soriot |
Executive Director,Chief Executive Officer |
英鎊 1.55M |
10/03/2026 |
| Dr. Aradhana Sarin |
Executive Director,Chief Financial Officer |
英鎊 990.00K |
10/03/2026 |
|
|
| Ms. Sherilyn S. McCoy |
Non-Executive Director |
10/03/2026 |
| Mr. Marcus Wallenberg |
Non-Executive Director |
10/03/2026 |
| Mr. Michel Roger Demare |
Non-Executive Director,Chairman |
10/03/2026 |
| Mr. Pascal Soriot |
Executive Director,Chief Executive Officer |
10/03/2026 |
| Mr. Philip A J Broadley |
Non-Executive Director,Senior Independent Director |
10/03/2026 |
| Ms. Anna Olive Magdelene Manz |
Non-Executive Director |
10/03/2026 |
| Ms. Diana Layfield |
Non-Executive Director |
10/03/2026 |
| Professor Nazneen Rahman |
Non-Executive Director |
10/03/2026 |
| Dr. Aradhana Sarin |
Executive Director,Chief Financial Officer |
10/03/2026 |
| Mr. Rene Haas |
Non-Executive Director |
10/03/2026 |
| Ms. Birgit M. Conix |
Non-Executive Director |
10/03/2026 |
| Professor Tony Mok |
Non-Executive Director |
10/03/2026 |
| Ms. Karen Knudsen |
Non-Executive Director |
10/03/2026 |
| Dr. Euan A. Ashley |
Non-Executive Director |
10/03/2026 |
|
|
|
|
